Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction

NCT03327649 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT03327649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03327649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction
Lead sponsor
University of Oklahoma
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2017
Completion date
September 30, 2021
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with normal ejection fraction